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Background: The clinical significance of bacteraemia secondary to non-typhoidal Salmonella (NTS) gastroenteritis in
hospitalised adults is uncertain.
Methods: Adults admitted to a hospital in Liverpool, UK, with NTS gastroenteritis were identified using hospital
discharge data and laboratory records. Patients with known HIV infection were excluded. Risk factors for a
complicated or fatal course were determined.
Results: Between 1982 and 2006 inclusive, 633 adults were identified. Serovars causing infection included Enteritidis
(46.6%), Typhimurium (27.6%) and Virchow (4.9%). A blood culture was taken in 364 (57.5%) patients who were generally
sicker than those who were not cultured. Bacteraemia was detected in 63 (17.3%) patients who had blood cultures taken
(63/633 (10.0%) of all patients). Bacteraemia was more common in those aged≥ 65 years (p < 0.001) and in those aged
< 65 years who had an underlying chronic disease. A complicated course occurred in 91 (25.0%) patients who had had a
blood culture taken (148/633 (23.4%) of all patients). Independent factors associated with a complicated or fatal course
among the patients investigated with a blood culture were bacteraemia (Adjusted Odds Ratio 5.34, 95% CI 2.86–9.95);
new onset confusion or coma (AOR 4.80, 95% CI 1.91–12.07); prolonged symptoms prior to admission (AOR 2.48, 95% CI
1.44–4.27); dehydration (AOR1.90, 95% CI 1.07–3.38); and absence of fever (AOR 0.56, 95% CI 0.32–0.95). The 30 day
attributable case fatality for all patients was 1.5%.
Conclusions: In this study secondary bacteraemia, as well as other clinical factors, was independently associated with a
complicated or fatal course in non-HIV infected adults admitted to hospital with NTS gastroenteritis.
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Non-typhoidal Salmonella (NTS) organisms are a com-
mon cause of bacterial food poisoning. The burden is sig-
nificant, with an estimated 93.8 million cases worldwide
and 155,000 deaths each year [1]. Clinical manifestations
range from subclinical infection to severe life-threatening
disease. Although NTS infections typically present with
diarrhoea that is self-limiting without the need for
antibiotic therapy they may also be complicated by* Correspondence: cmparry@liverpool.ac.uk
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reproduction in any medium, provided the orextraintestinal infection, including bacteraemia that is
primary (in the absence of recent or current including
mild and clinically ignored gastroenteritis), or second-
ary (secondary to gastroenteritis) [2,3]. Primary bacter-
aemia is linked with a high mortality and is associated
with underlying malignancy and immunosuppression, and
infection with particular serovars such as Choleraesuis
[2-4]. The incidence and significance of secondary bac-
teraemia is less clear. Many studies mix primary and
secondary cases together and patients with apparently
uncomplicated gastroenteritis are usually not inves-
tigated with a blood culture [5-15]. The extent to which
secondary bacteraemia contributes to poor outcomes in
NTS gastroenteritis is uncertain.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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adults admitted to hospital with NTS gastroenteritis in
Liverpool, UK during a twenty five year period. The pur-
pose of this study was to determine the clinical signifi-
cance of secondary bacteraemia and in particular if it is
important in contributing to adverse outcome in this
group of patients.
Methods
Study design
This was a retrospective case note review of all adults with
NTS gastroenteritis admitted to a single centre. Ethical
approval for the study was given by the Fazakerley and
Walton Hospitals Research Ethics Committee. All clinical
samples taken were part of standard care.
Data source and collection
Case notes were reviewed for all adults admitted to
University Hospital Aintree (previously Fazakerly and
Walton Hospitals) Liverpool, with infections due to
Salmonella species between 1st January 1982 and 31st
December 2006 inclusive. The hospital has over 800
beds, including a Regional Infectious Disease Unit (until
2002) where the majority of these patients were managed.
Cases were identified from: microbiology laboratory re-
cords, Hospital Activity Analysis computer records of in-
patient stays and discharge diagnoses, and the manual and
computerised patient registers of the Infectious Disease
Unit. Clinical and laboratory data for each patient were
recorded on a standardised case report form.
Patients > 15 years old, with a diagnosis of acute NTS
gastroenteritis were included. Gastroenteritis was con-
sidered acute if the onset was ≤ 14 days prior to admis-
sion. Known chronic faecal carriers, faecal carriers
without gastroenteritis on admission, those with a pri-
mary extra-intestinal infection, those with healthcare
associated infection (infection onset > 48 hours after ad-
mission), patients with non-acute infection (ill for more
than 14 days prior to admission), and patients with
known HIV/AIDS were excluded from the analysis.
Bacteriology
Blood cultures were performed using the BACTECW sys-
tem (Becton Dickinson, UK). Faecal samples were
cultured on routine bacteriology media used for enteric
pathogens (all media, Oxoid, Basingstoke, UK). The
isolated organisms were identified by standard biochem-
ical tests including the API system (bioMérieux, UK)
and serotyping with specific antisera (BioRad, UK). The
identification and serovar of isolates was confirmed by
the Laboratory for Gastrointestinal Pathogens, Health
Protection Agency, Colindale and phage typing was
performed for serovar Enteritidis and Typhimurium.
Antibiotic susceptibility tests were not performed onSalmonella isolates from faeces. Invasive isolates were
tested by disk susceptibility to ampicillin, co-trimoxazole
and, from 1987 onwards, ciprofloxacin. Nalidixic acid
testing was not done and isolates were not retrievable
for additional testing.
Definitions
The following definitions were used: elderly - ≥ 65 years at
admission; chronic underlying disease – the presence of
hypertension, ischaemic heart disease, valvular heart dis-
ease, congestive heart failure, peripheral vascular disease,
cerebrovascular disease, chronic pulmonary disease, renal
impairment, chronic liver disease, inflammatory bowel dis-
ease, connective tissue disease, diabetes mellitus, dementia
or malignancy; vascular and valvular heart disease – the
presence of hypertension, ischaemic heart disease, valvular
heart disease, congestive cardiac failure, cerebrovascular
disease, peripheral vascular disease or diabetes mellitus;
hypochlorhydria – documented past gastric surgery, per-
nicious anaemia, or current H2 antagonist or proton pump
inhibitor therapy (H2A/PPI); fever – temperature > 38°C
during the first 24 hours of admission; tachycardia – pulse
>90/minute; hypotension – systolic blood pressure <90
mmHg; dehydration – loss of normal skin turgor or dry
mucous membranes; mental impairment – an abnormal
state of consciousness; anaemia - haemoglobin <11 g/dl in
females and <13 g/dl in males; leucocytosis –white blood
cell count >12.0 × 109/L; leucopenia - white blood cell
count of <4 × 109/L; elevated urea – urea >7.5 mmol/l;
bacteraemia – one or more blood cultures positive for
Salmonella spp; bacteriuria – one or more urine cultures
positive for Salmonella spp, plus one or both of urinary
symptoms or urine white cell count ≥50 cells/μL.
Secondary bacteraemia was defined by the isolation of
Salmonella from blood following an episode of gastro-
enteritis in the previous month associated with the isola-
tion of the same Salmonella from faeces and from no
other site except faeces. The bacteraemia was defined as
community acquired bacteraemia if the onset was in the
community or within 48 hours of hospital admission. Sal-
monella carriage was defined by the isolation of salmonella
from faeces on one or more occasions in the absence of
any relevant gastrointestinal symptoms. Complicated dis-
ease was defined on the basis of clinical features and, in
some instances, culture positivity. Complicated disease
included: any gastrointestinal complication excluding post
infection Salmonella faecal carriage; extra-intestinal com-
plications including a vascular event or evidence of vascu-
lar infection; clinical evidence of pneumonia; evidence of a
urinary tract infection with NTS (urine microscopy evi-
dence of ≥50 leucocytes/μL and ≥ 105/L pure growth of
NTS); reactive arthritis or uveitis; the general complications
of infection including hypotension; renal impairment (new
creatinine >300 mmol/l with urea >7.5 mmol/l); a new
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ation >14 days; or fatal disease. We considered most
patients with NTS gastroenteritis would be admitted to
hospital for less than two weeks and that a prolonged
admission of more than two weeks was an adverse out-
come of the illness. Although there are many reasons
why the duration of admission could be prolonged, and
difficult to disentangle in a retrospective study, in most
instances the prolonged admission was directly related
to the initial nfection. The attributable case fatality was
the proportion of deaths that occurred in hospital, in
the period up to 30 days following admission, and that
were considered attributable to the NTS infection.
Analysis
Non-normally distributed variables were compared using
the Mann-Whitney U test. Categorical variables were
compared using the Chi squared test, or Fisher’s exact
test. A significance level of p <0.05 was used for all ana-
lyses. Variables found to be significant on univariable
analysis were entered into a backward logistic regression
model, and adjusted odds ratios calculated for each vari-
able. Cases with data missing for the variables entered
into the logistic regression were excluded from this ana-
lysis [16]. All statistical analysis was performed using
SPSS for Windows v 18 (SPSS inc, Chicago, USA) and
Epi-info software (CDC, Atlanta, USA).
Results
A total of 754 patients with a Salmonella isolated from
any site were identified. 121 patients were excluded: 40
with non-typhoidal faecal Salmonella carriage; 16 with
healthcare associated Salmonella infection; 14 patients
under 16 years of age; 25 with pre-admission symptoms
for longer than 14 days; 12 with serovar Typhi or
Paratyphi; 12 with primary extra-intestinal infections;
and two with known HIV/AIDS. The remaining 633
patients were included in the analysis. The characte-
ristics of the 633 patients are in Table 1. There were 202
(31.9%) patients with documented chronic disease prin-
cipally vascular and valvular heart disease (99); hypo-
chlorhydria (71); chronic lung disease (22); malignancy
(15) and connective tissue disease (12). Figure 1 shows
the age distribution of cases.
Enteritidis and Typhimurium were the commonest
serovars isolated from stool and blood although Virchow
and Panama were more commonly associated with bac-
teraemia (Table 2). Among the serovar Enteritidis iso-
lates, 160/294 (54%) were phage type 4 (PT4) and for
Typhimurium 27/174 (15%) were phage type DT104. In
the early 1980s Typhimurium was the dominant serovar,
but was replaced by Enteritidis by the end of the de-
cade (Figure 2). Total cases peaked in 1988, accounted
for by high numbers of Enteritidis and Typhimurium.Enteritidis remained the dominant serovar during the
1990s. The total number of Salmonella cases declined
from 1998 onwards. Each year cases peaked in the sum-
mer months.
Blood cultures were taken from 364 patients and they
were significantly more likely to have had <4 days of
symptoms before admission, a history of vomiting, fever,
rigors, and headache on admission and pyrexia, tachycar-
dia, dehydration and mental impairment on examination,
and leuocytosis (Table 1). NTS was cultured from the
blood of 63 patients, 10.0% of total, and 17.3% of those
with blood cultures taken. Bacteraemic patients were sig-
nificantly more likely to be ≥ 65 years old, with an under-
lying chronic disease including hypochlorhydria, to have a
low systolic blood pressure with dehydration, mental im-
pairment, and an elevated urea (Table 1). There was a sig-
nificant increase in the proportion of patients with
bacteraemia over time (31/222 (14.0%) during 1982–1991
compared with 32/142 (22.5%) during 1992–2006 (p =
0.046). In adults under 65 years the proportion of positive
blood cultures was 12/63 (19.0%) in those with, and 24/
225 (10.7%) in those without underlying chronic disease.
For those 65 years or older the corresponding proportions
were 17/50 (34.0%) in those with underlying disease and
10/26 (38.5%) in those without (Table 3). In a multi-
variable analysis, a positive blood culture was independ-
ently associated with an elevated urea (OR 3.38; 95% CI
2.30–7.68, p < 0.001) and mental impairment (OR 3.07,
95% CI 1.27–7.43. p = 0.013). All tested isolates were sus-
ceptible to ciprofloxacin by prevailing guidelines but
ciprofloxacin MIC testing or nalidixic acid susceptibility
was not performed.
Antibiotics were prescribed after hospital admission in
286 (45%) of the 633 patients and in 54 (86%) of the 63
patients with a positive blood culture. Ciprofloxacin was
prescribed in 198 (69%) of the 286 cases where an anti-
biotic was prescribed and was first used in 1987. Be-
tween 1987 and 1996 it was used in 157/188 (84%) of
cases and between 1997 and 2006 it was used in 41/58
(71%) of cases. Other antibiotics commonly prescribed
were: an injectable second or third generation cephalo-
sporin (n = 33); co-trimoxazole or trimethoprim (n = 31);
and ampicillin (n = 23).
The main complications were gastrointestinal or pro-
longed hospital stay (Table 3). The proportion of pa-
tients with a complication did not change significantly
over time (97/397 (24.4%) during 1982–1991 compared
with 51/236 (21.6%) during 1992–2006 (p = 0.439). Vas-
cular complications only occurred in those ≥ 65 years
old, and no patients had a confirmed endovascular infec-
tion or endocarditis. Of the 13 patients with both bacter-
aemia and underlying vascular or valvular heart disease,
all but one aged ≥50 years, only one developed a
diagnosed vascular complication. This patient had a
Table 1 Characteristics of 633 adults admitted to hospital with non-typhoidal Salmonella gastroenteritis in Liverpool
between 1982 and 2006 and of the 364 patients who had a blood culture taken
All
patients
Patients with blood
culture taken
Patients with no
blood culture taken
p1 Positive blood
culture
Negative
blood culture
p2
Number 633 364 269 63 301
Median age (IQR, range) years 40 (26–64,16-98) 39 (26–61,16-91) 42 (26–68,19-98) 0.083 62 (36–75,16-91) 35 (25–53,16-90) <0.001
Age ≥ 65 years 150 (23.7) 76 (20.9) 74 (27.5) 0.059 27 (42.9) 49 (16.3) <0.001
Male gender 300 (47.4) 171 (47.0) 129 (48.0) 0.810 31 (49.2) 140 (46.5) 0.782
Current smoker 216 (34.1) 113 (31.0) 103 (38.3) 0.573 20 (31.7) 93 (30.9) 0.895
Current alcohol user 369 (58.3) 224 (61.5) 145 (53.9) 0.541 35 (55.6) 189 (62.8) 0.283
Recent travel history 79 (12.5) 49 (13.5) 30 (11.2) 0.398 7 (11.1) 42 (14.0) 0.686
Chronic disease 202 (31.9) 113 (31.0) 89 (33.1) 0.605 29 (46.0) 84 (27.9) 0.007
Hypochlorhydria 71 (11.2) 39 (10.7) 32 (11.9) 0.703 13 (20.6) 26 (8.6) 0.012
Recent antibiotic therapy 56 (8.8) 32 (8.8) 24 (8.9) 1.00 2 (3.2) 30 (10.0) 0.091
Duration symptoms > 4 days 255 (40.3) 134 (36.8) 121 (45.0) 0.041 26 (41.3) 108 (35.9) 0.473
Bloody diarrhoea 126 (19.9) 65 (17.9) 61 (22.7) 0.158 16 (9.5) 59 (19.6) 0.070
Abdominal pain 493 (77.9) 284 (78.0) 209 (77.7) 0.923 44 (69.8) 240 (79.7) 0.095
Vomiting 427 (67.5) 265 (72.8) 162 (60.2) 0.001 47 (74.6) 218 (72.4) 0.876
Pyrexia 234 (37.0) 199 (49.5) 54 (20.1) <0.001 27 (42.9) 153 (50.8) 0.270
Rigors 95 (15.0) 83 (22.8) 12 (4.5) <0.001 8 (12.7) 75 (24.9) 0.046
Headache 142 (22.4) 108 (29.7) 34 (12.6) <0.001 15 (23.8) 93 (30.9) 0.291
Cough 46 (7.3) 32 (8.8) 14 (5.2) 0.091 7 (11.1) 25 (8.3) 0.466
Admission temperature > 38°C 3 124 (19.7) 108 (29.9) 16 (6.0) <0.001 17 (27.0) 91/298 (30.5) 0.683
Admission pulse > 90/min 4 242 (38.5) 151 (41.8) 91 (34.1) 0.006 32 (51.6) 119/299 (39.8) 0.112
Admission systolic blood
pressure < 90 mmHg 4
13 (2.1) 11 (3.1) 2 (0.8) 0.084 6 (10.0) 5 (1.7) 0.004
Dehydration 321 (50.7) 215 (59.1) 106 (39.4) <0.001 45 (71.4) 170 (56.5) 0.034
Abdominal tenderness 330 (52.1) 199 (54.7) 131 (48.7) 0.148 29 (46.0) 170 (56.5) 0.164
Mental impairment 34 (5.4) 27 (7.2) 7 (2.6) 0.007 12 (19.0) 15 (5.0) 0.001
Lecocytosis 5 92 (14.8) 66 (18.2) 26 (10.1) 0.008 15 (23.8) 51/300 (17.0) 0.274
Leucopenia 6 27 (4.4) 19 (5.2) 8 (3.1) 0.235 5 (7.9) 14 (4.7) 0.345
Anaemia 7 44 (7.1) 29 (8.0) 15 (5.9) 0.344 6 (9.5) 23 (7.7) 0.611
Elevated urea 8 189 (30.6) 113 (31.4) 76 (29.6) 0.658 39 (61.9) 74 (24.9) < 0.001
Data are number (%), except where stated.
1 Comparison of patients with blood culture taken and patients without blood culture taken.
2 Comparison of patients with a positive blood culture and patients with a negative blood culture among the 354 patients who had a blood culture taken.
3 n = 628.
4 n = 605.
5 White blood cell count >12.0 × 109/L; n = 620.
6 White blood cell count <4.0 × 109/L; n = 620.
7 Haemoglobin <11 g/dl in females and <13 g/dl in males; n = 619.
8 Urea >7.5 mmol/l; n = 617.
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vascular accident and subsequently died. A further four
of these 13 patients developed acute renal failure sec-
ondary to shock (n = 1) or dehydration (n = 3) and it is
possible they had an undiagnosed endovascular lesion.
Three of these 13 patients were treated with ciprofloxacin,
but these did not include the patients who developed
complications. No patient developed osteomyelitis al-
though reactive arthritis and/or uveitis occurred in nine
(1.4%) patients, all aged below 50 years. A Salmonellaurinary infection was present in 15 (2.4%) of all patients
and 15/466 (3.2%) patients who had a urine cultured.
There were no known urinary tract anatomical abnormal-
ities in these patients. Of patients who had both blood and
urine cultured 5/12 (41.7%) patients with a Salmonella
bacteruria were also bactaeremic compared with 48/290
(16.6%) who were not bacteruric (p = 0.041).
Fourteen patients were known to have died within
6 months of admission. All deaths were in patients
older than 55 years and rose with increasing age (Figure 1).
Case Fatality Rate
0% 0% 0% 0% 2.0% 6.8% 10.9%        20.0%
Figure 1 Number of cases, fatal cases and case fatality rates by age group in 633 adults admitted to a hospital in Liverpool, UK with
non-typhoidal Salmonella gastroenteritis.
Parry et al. BMC Infectious Diseases 2013, 13:107 Page 5 of 10
http://www.biomedcentral.com/1471-2334/13/107The youngest was a man of 57 years with alcoholic liver
disease. Salmonella made a significant contribution to
death in nine of the patients who died in hospital within
30 days of admission giving an attributable 30 day case
fatality rate of 1.5%.Table 2 Serovar distribution of Salmonella in blood and faece
Serovar Number of
isolates from
faeces (%)
Number of isolates
from faeces in patien
with blood culture done
Total samples 633 (100) 364 (100)
Enteritidis 295 (46.6) 183 (50.3)
Typhimurium 175 (27.6) 96 (15.2)
Virchow 31 (4.9) 23 (6.3)
Panama 11 (1.7) 5 (1.4)
Kedougou 8 (1.3) 3 (0.8)
Hadar 7 (1.1) 3 (0.8)
Stanley 6 (1.0) 2 (0.6)
Newport 5 (0.8) 4 (0.8)
Anatum 5 (0.8) 2 (0.5)
Agona 4 (0.6) 2 (0.5)
Heidelberg 4 (0.6) 2 (0.5)
Infantis 4 (0.6) 0 (0)
Montevideo 4 (0.6) 2 (0.5)
Braenderup 3 (0.5) 1 (0.3)
Mbandka 1 (0.2) 1 (0.3)
New Brunswick 1 (0.2) 1 (0.3)
Stanleyville 1 (0.2) 1 (0.3)
Untyped 50 (7.9) 27 (7.4)
Other 18 (2.8) 6 (1.6)The proportion of patients with complicated or fatal
disease in the group of patients who had a blood culture
taken was 91/364 (25.0%) and was not significantly dif-
ferent from 57/269 (21.2%) in those patients who were
not cultured (p = 0.269). The type of complications dids for 633 adults
ts
(%)
Number of
isolates from
blood (%)
Percentage of patients with
faecal isolate also bacteraemic
when blood culture done
63 (100) 17.3
30 (47.6) 16.4
9 (14.3) 9.4
7 (11.1) 30.4
4 (6.3) 80.0
0 (0) 0
1 (1.6) 33.0
0 (0) 0
2 (3.2) 50.0
0 (0) 0
0 (0) 0
2 (3.2) 100
0 (0) 0
0 (0) 0
1 (1.6) 100
1 (1.6) 100
1 (1.6) 100
1 (1.6) 100
4 (6.3) 14.8
0 (0) 0
Figure 2 Overall number of cases of non-typhoidal Salmonella gastroenteritis admitted to a hospital in Liverpool, UK between 1982
and 2006 inclusive by year and the number of cases due to serovar Typhimurium and serovar Enteritidis.
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patients who had a blood culture taken, complicated or
fatal disease was significantly more common in the eld-
erly, those with chronic disease, hypochlorhydria, dur-
ation of symptoms > 4 days prior to admission, the
absence of a history of fever, the presence of symptoms
of dehydration and new onset confusion or coma at the
time of admission, leucocytosis, elevated urea and a
positive blood culture for salmonella (Table 4). In a
multivariable model, bacteraemia; new onset confusion
or coma; duration of symptoms > 4 days prior to admis-
sion; dehydration; and the absence of a history of fever
remained significant. There were five (11.9%) deaths in
the 42 patients aged 50 years or more with bacteraemia
but none in the 21 bactaeremic patients aged below
50 years.
Discussion
In this large cohort of adults admitted with community
acquired NTS gastroenteritis to a single hospital centre
over a 25-year period, secondary bacteraemia occurred
in 17.3% of patients cultured and 10.0% overall. These
secondary bacteraemia figures are higher than the 6.7%,
7% and 3.8% reported in other adult studies [8-10] and
6.5% to 11.8% in children [6,7,12,14]. Only two of these
studies performed blood cultures on every patient [7,10].
In the current study secondary bacteraemia occurred in
one in ten healthy adults aged <65 years who had a cul-
ture taken, consistent with the data from healthychildren, but almost one in five of those with underlying
disease. In elderly patients (≥ 65 years) one third had
bacteraemia and, unlike the younger adults, this propor-
tion did not vary significantly between those with, and
without, chronic underlying disease. The reason for the
higher level of secondary bacteraemia is difficult to de-
termine in this retrospective study. Patients may have
been more likely to have had blood cultured as many
were admitted to the infectious diseases ward where this
is routine. The contribution of antibiotic resistance can-
not be determined because of the lack of susceptibility
data on the isolates.
This study suggests that secondary bacteraemia, new
onset confusion or coma, a prolonged duration of
symptoms before admission, dehydration and the ab-
sence of a history of fever are significantly associated
with a complicated or fatal disease in non-HIV infected
adults admitted to hospital with NTS gastroenteritis.
Age and underlying chronic disease did not remain in
the final model and suggest that bacteraemia, prolonged
disease and dehydration are the critical factors leading
to a complicated outcome. Clinical features such as
rigors, fever, tachycardia, or leucocytosis did not distin-
guish bacteraemic from non-bacteraemic patients. Al-
though an association of fever or prolonged fever has
been found with bacteraemia in children [7,12], a study
of 105 adults, found that the presence of fever or
neutrophilia was not significantly associated with bacter-
aemia [9]. Bacteraemia was more common in infections
Table 3 Comparison by age group of the outcome in 633 adults admitted to hospital with non-typhoidal Salmonella
gastroenteritis in Liverpool between 1982 and 2006 inclusive
All patients Age < 65 years
with no
underlying
chronic disease
Age < 65 years
with underlying
chronic disease
p1 Age ≥ 65 years
with no
underlying
chronic disease
Age ≥ 65 years
with underlying
chronic disease
P2
Number 633 381 102 50 100
Bacteremia 63/364 (17.3) 24/225 (10.7) 12/63 (19.0) 0.086 10/26 (38.5) 17/50 (34.0) 0.802
Given intravenous fluids 367 (58.0) 206 (54.1) 63 (61.8) 0.790 34 (68.0) 64 (64.0) 0.717
Given antibiotic in hospital 286 (45.2) 155 (40.7) 45 (44.1) 0.572 25 (50.0) 61 (61.0) 0.223
All complications 148 (23.4) 54 (14.2) 22 (21.6) 0.095 22 (44.0) 50 (50.0) 0.603
Specific complications 3
Duration of admission > 21 days 66 (10.4) 14 (3.7) 11 (10.8) 0.009 12 (24.5) 30 (30.0) 0.563
Gastrointestinal complication 4 44 (7.0) 21 (5.5) 10 (9.8) 0.169 1 (2.0) 12 (12.0) 0.061
Renal impairment 26 (4.1) 4 (1.0) 6 (5.9) 0.008 8 (16.0) 8 (8.0) 0.163
Urinary tract infection 15 (2.4) 10 (2.6) 0 (0) 0.130 0 (0) 5 (5.0) 0.170
Pneumonia 14 (2.2) 2 (0.5) 2 (2.0) 0.198 3 (6.0) 7(7.0) 1.00
Hypotension 13 (2.1) 3 (1.0) 4 (4.0) 0.039 2 (4.0) 4 (4.0) 1.00
Reactive arthritis/uveitis 9 (1.4) 8 (2.1) 1 (1.0) 0.692 0 (0) 0 (0) -
Central nervous complication 5 5 (0.8) 0 (0) 2 (2.0) 0.044 2 (4.0) 1 (1.0) 0.258
Vascular complication 6 4 (0.6) 0 (0) 0 (0) - 1 (2.0) 3 (3.0) 1.00
Total deaths 14 (2.2) 0 (0) 1 (1.0) 0.211 1 (2.0) 12 (12.0) 0.061
Attributable deaths 9 (1.4) 0 (0) 1(1.0) 0.211 1 (2.0) 7 (7.0) 0.270
Data are number (%), except where stated.
1 Univariate statistical comparison of those age < 65 with no underlying disease versus age < 65 with underlying disease.
2 Univariate statistical comparison of those age ≥ 65 with no underlying disease versus age ≥ 65 with underlying disease.
3 14 patients with site specific complications had more than one site affected.
4 Ileus/subacute obstruction (7); severe colitis (7); prolonged diarrhoea (diarrhoea persisting for > two weeks) (6); irritable bowel syndrome (5); Clostridium difficile
colitis (3); appendicitis (2); recurrent diarrhoea (recurrence of diarrhoea after intial recovery) (2); toxic colonic dilatation (2); erosive gastritis (1); exacerbation of pre-
existing inflammatory bowel disease (1); gastrointestinal bleeding (1); persistent vomiting (1).
5 Acute confusion (3), coma with possible encephalopathy (2).
6 Cerebrovascular accident (2); pulmonary embolus, gangrene and cerebrovascular accident (1); septic thrombophlebitis (1).
Parry et al. BMC Infectious Diseases 2013, 13:107 Page 7 of 10
http://www.biomedcentral.com/1471-2334/13/107with serovar Virchow and Panama, as recognized in
other studies [10,17,18].
Complicated disease developed in almost one quarter of
patients, with gastrointestinal complications and a pro-
longed hospital stay reported most frequently. The range
of complications was consistent with other studies except
for a notable lack of endovascular infection [2,19]. Previ-
ous studies have reported endovascular infections occur-
ring in between 7 and 41% of cases of NTS bacteraemia in
adults aged >50 years [11,20-22]. Our study found only
one diagnosed vascular complication among 42 bacter-
aemic patients aged >50 years. It is possible that the risk
may be less than has previously been reported, that less
invasive serovars are seen at this centre or that this com-
plication was simply under-diagnosed as routine CT scan-
ning was not performed. The occurrence of reactive
arthritis or uveitis in 1.4% of patients, all younger than
50 years, was consistent with previous studies [23] but the
2.4% of patients with a urinary infection was higher than
expected [19,24]. The absence of renal tract abnormalities
or immunosuppression and the finding that 42% ofbacteriuric patients were bacteraemic suggests infection
secondary to bacteraemia rather than an ascending urinary
infection [24]. Almost all the deaths were in patients aged
65 years or more [8,9]. Studies that report deaths in
younger patients tend to be from earlier studies or include
primary extra-intestinal infections [5,25,26]. Although
more patients with severe illness and complicated out-
comes received antibiotics after admission, the retrospect-
ive nature of this study does not allow examination of
their effectiveness. It is notable, however, that almost one
third of patients over 65 years were not given an antibiotic
after admission to hospital, and this even included some
patients who had a complicated course, and suggests that
the need for antibiotics in this age group is insufficiently
recognised.
This study was limited by being retrospective. Data
were collected on a standardised case report form over
the whole of the twenty-five year period, and where pos-
sible, the inaccuracies associated with retrospective data
have been minimised. The study was restricted to
hospital-admitted and bacteriologically-proven cases. A
Table 4 Univariate clinical and demographic associations with complicated or fatal disease in 364 adults admitted to
hospital with non-typhoidal Salmonella gastroenteritis who had a blood culture taken
Complicated or
fatal disease
Uncomplicated
disease
OR (95% CI) p1 Adjusted OR
(95% CI)
p2
Number (%) 91 (25.0) 273 (75.0)
Age≥ 65 years 35 (38.5) 41 (15.0) 3.54 (2.07–6.05) <0.001
Male gender 37 (40.7) 134 (49.1) 0.71 (0.44–1.15) 0.183
Current smoker 30 (33.0) 83 (30.4) 1.13 (0.66–1.93) 0.110
Current alcohol user 48 (52.7) 176 (64.5) 0.06 (0.37–1.02) 0.062
Recent travel history 14 (15.4) 35 (12.8) 1.24 (0.63–2.42) 0.595
Chronic disease 41 (45.1) 72 (26.4) 2.29 (1.40–3.75) 0.002
Hypochlorhydria 15 (16.5) 24 (8.8) 2.05 (1.02–4.10) 0.050
Recent antibiotic therapy 7 (7.7) 25 (9.2) 0.83 (0.35–1.98) 0.831
Duration symptoms > 4 days 47 (51.6) 87 (31.9) 2.28 (1.41–3.70) 0.001 2.48 (1.44–4.27) 0.001
Bloody diarrhoea 14 (15.4) 51 (18.7) 0.79 (0.42–1.51) 0.530
Abdominal pain 69 (75.8) 215 (78.8) 0.85 (0.48–1.48) 0.561
Vomiting 65 (71.4) 200 (73.3) 0.91 (0.54–1.55) 0.786
Pyrexia 35 (38.5) 145 (53.1) 0.55 (0.34–0.90) 0.016 0.56 (0.32–0.95) 0.033
Rigors 14 (15.4) 69 (23.5) 0.54 (0.29–1.01) 0.060
Headache 20 (22.0) 88 (32.2) 0.59 (0.34–1.03) 0.065
Cough 11 (12.1) 21 (7.7) 1.65 (0.76–3.57) 0.204
Admission temperature > 38°C 3 24 (26.4) 84 (31.1) 0.81 (0.46–1.42) 0.508
Admission pulse > 90/min 4 46 (50.5) 105 (38.9) 1.61(1.00–2.59) 0.065
Dehydration 67 (73.6) 148 (54.2) 2.36 (1.40–3.98) 0.001 1.90 (1.07–3.38) 0.029
Abdominal tenderness 44 (48.4) 155 (56.8) 0.71 (0.44–1.15) 0.182
Mental impairment 18 (19.8) 9 (3.3) 7.23 (3.12–16.77) <0.001 4.80 (1.91–12.07) 0.001
Leococytosis 5 25 (27.5) 41 (15.1) 2.13 (1.21–3.77) 0.012
Leucopenia 6 4 (4.4) 15 (5.5) 0.79 (0.26–2.44) 0.792
Anaemia 7 9 (9.9) 20 (7.4) 1.38 (0.61–3.16) 0.503
Elevated urea 8 46 (50.5) 67 (24.9) 3.08 (1.88–5.06) < 0.001
Serovar Enteritidis infection 47 (51.6) 136 (49.8) 1.08 (0.65–1.78) 0.856
Serovar Typhimurium infection 18 (19.8) 78 (28.6) 0.62 (0.33–1.14) 0.131
Serovar Virchow infection 7 (7.7) 16 (5.9) 1.34 (0.48–3.61) 0.709
Positive blood culture 37 (40.7) 26 (9.5) 6.51 (3.64–11.64) <0.001 5.34 (2.86–9.95) 0.001
Data are number (%), except where stated.
1 Univariable comparison of patients with complicated or fatal disease compared with those with uncomplicated disease.
2 Adjusted comparison from multivariable logistic regression.
3 n = 361.
4 n = 354.
5 White blood cell count >12.0 × 109/L; n = 363.
6 White blood cell count <4.0 × 109/L; n = 363.
7 Hemoglobin <11 g/dl in females and <13 g/dl in males; n = 363.
8 Urea >7.5 mmol/l; n = 360.
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http://www.biomedcentral.com/1471-2334/13/107further important limitation was that not all patients
had a blood culture taken and that those cultured were
sicker than those who were not. We excluded patients
known to be HIV infected but cannot be completely cer-
tain that some were not missed as HIV testing was not
routinely performed in this patient group over the
course of the study. During this period most HIV posi-
tive adults in the Liverpool area requiring hospitaladmission were admitted to the same hospital unit, and
the prevalence of HIV in the Liverpool area was low. We
cannot be sure that bacteraemia isolates were susceptible
to ciprofloxacin because none had an MIC performed or
testing for nalidixic acid susceptibility. Nalidixic acid re-
sistant isolates with decreased ciprofloxacin susceptibil-
ity have been associated with a three-fold increased risk
of invasive disease and death in adults in Denmark [27].
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http://www.biomedcentral.com/1471-2334/13/107The study is representative of nationally reported
trends in NTS infections in the last 25 years. Peaks of
cases in the 1980s and 1990s coincided with the epi-
demic in serovar Enteritidis PT4 cases linked to poultry
and eggs. The decline in the last decade has been
attributed to better animal husbandry, vaccination of
chicken flocks and improved kitchen hygiene [28].Conclusions
In conclusion, this study suggests that secondary bacter-
aemia is associated with an adverse outcome in non-
HIV infected adults admitted to hospital with NTS
gastroenteritis. Blood cultures should be performed in
adults ill enough to be admitted to hospital with gastro-
enteritis. Antibiotic therapy, in addition to careful rehy-
dration, should be considered in patients at high risk of
secondary bacteraemia, including elderly patients (>65
years) and younger adults with relevant underlying
chronic conditions [29,30].
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